Home > Insider Trading > Filing (0000849146-25-000056)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
849146	Lifevantage Corp	LFVN	Pharmaceutical Preparations (2834)	900224471

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1891462	Carl Aure	3300 N. Triumph Blvd Suite 700 Lehi UT 84043	Chief Financial Officer	No	Yes	No	No

Transaction Summary

Sold:	2,746 shares	Avg. Price: $13.39	Total Value: $36,768.94
Number of Shares After Transactions:	133,303 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-07-01	2,401	$0.00	136,049	No	4	M	Direct
Common Stock	Disposition	2025-07-01	2,746	$13.39	133,303	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Restricted Stock Units	Disposition	2025-07-01	2,401	$0.00	2,401	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

On August 18, 2022, the Reporting Person was granted PSUs which vest only to the extent specified financial performance criteria are achieved and subject to the Reporting Person's continued service with the Issuer, as follows: (i) 1/3 of the earned award vested on the first anniversary of the grant date and (ii) an additional 1/12 of the earned award will vest on the first day of each calendar quarter thereafter. The Reporting Person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target; accordingly, the Reporting Person is eligible to earn 133.13% of the target number of units. The actual number of shares that vested on the reported transaction date was 133.13% of the at-target number of shares subject to vesting on that date and the number of PSUs beneficially owned following the reported transaction has been updated to reflect the new target number of units.
Includes 1,590 total shares purchased on February 28, 2025 under the Employee Stock Purchase Plan.
Performance Restricted Stock Units ("PSUs") convert into common stock on a one-for-one basis.